Efficacy and Safety of Ranibizumab 0.5 mg with/without Laser Versus Laser Alone in Patients with Branch Retinal Vein Occlusion: 6-Month Outcomes from the Brighter Study

OPHTHALMOLOGICA(2014)

Cited 0|Views4
No score
Key words
Ranibizumab,Retinal Vein Occlusion,BRVO,Macular Edema
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined